Institutional Ownership
Corvus Pharmaceuticals Inc
CUSIP 221015100COMCRVSQ1 2026
13D / 13G Filings
44
Schedule 13D/13G on record
Beneficial Filers
17
Distinct reporting persons
Largest Stake
24.2%
Max % of class reported
Institutional Holders
160
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
44 filings · latest Feb 13, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 13, 2026 | Richard A. Miller | 13G/A | 7.8% | 6.09M | SEC |
| 2 | Feb 5, 2026 | Adams Street Partners, LLC | 13D/A | 3.9% | — | SEC |
| 3 | Jan 30, 2026 | The Vanguard Group | 13G | 5.2% | 3.87M | SEC |
| 4 | Jan 27, 2026 | Orbimed Advisors LLC | 13D/A | 10.3% | — | SEC |
| 5 | Oct 17, 2025 | Blackrock, Inc. | 13G | 5.4% | 4.02M | SEC |
| 6 | Aug 14, 2025 | Samlyn Capital, LLC | 13G/A | — | — | SEC |
| 7 | May 15, 2025 | Samlyn Capital, LLC | 13G/A | 6.0% | — | SEC |
| 8 | May 14, 2025 | Orbimed Advisors LLC | 13D/A | 12.2% | — | SEC |
| 9 | May 1, 2025 | Orbimed Advisors LLC | 13D/A | 13.8% | — | SEC |
| 10 | Feb 14, 2025 | Samlyn Capital, LLC | 13G/A | 9.8% | — | SEC |
34 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Corvus Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.17M | $104.82M |
| 2 | Blackrock, Inc. | 6.16M | $90.13M |
| 3 | State Street Corp | 3.57M | $52.17M |
| 4 | Adams Street Partners LLC | 3.28M | $47.92M |
| 5 | Vivo Capital, LLC | 2.81M | $41.05M |
| 6 | Morgan Stanley | 2.50M | $36.56M |
| 7 | Deep Track Capital, LP | 2.49M | $36.45M |
| 8 | Wellington Management Group LLP | 2.32M | $33.92M |
| 9 | Perceptive Advisors LLC | 2.29M | $33.54M |
| 10 | Commodore Capital LP | 2.26M | $33.05M |